SCHEMBL1744973

SCHEMBL1744973

COC(=O)CCc1ccc(OCc2cc(Br)ccc2Cl)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 9/20 0.49
FFAR4 Q5NUL3 8/20 0.49
ADRB2 P07550 1/20 0.45
ADRB1 P08588 1/20 0.45
IDO1 P14902 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
POLB P06746 1/20 0.43
VDR P11473 1/20 0.42
PPARD Q03181 1/20 0.42
MAOB P27338 1/20 0.42
ALDH1A1 P00352 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41
TSHR P16473 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1746557 0.86 FFAR1 (0.67) FFAR1FFAR4
SCHEMBL1746594 0.83 FFAR1 (0.49) FFAR1FFAR4ADRB2ADRB1VDR
SCHEMBL1745033 0.83 FFAR1 (0.54) FFAR1FFAR4VDRPPARD
SCHEMBL2828491 0.82 FFAR1 (0.71) FFAR1FFAR4ADRB2ADRB1IDO1
SCHEMBL15211590 0.81 NR4A2 (0.59) FFAR1FFAR4ADRB2ADRB1IDO1
SCHEMBL1743642 0.79 FFAR1 (0.74) FFAR1FFAR4MAOB
SCHEMBL15265470 0.76 FFAR4 (0.53) FFAR1FFAR4ADRB2ADRB1VDR
SCHEMBL516422 0.76 IDO1 (0.65) FFAR1FFAR4ADRB2ADRB1IDO1
SCHEMBL17028531 0.75 FFAR1 (0.52) FFAR1FFAR4ADRB2ADRB1VDR
SCHEMBL1745243 0.74 FFAR1 (0.61) FFAR1FFAR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1559422-B1 RECEPTOR FUNCTION CONTROLLING AGENT TAKEDA PHARMACEUTICAL (JP) 2014-04-30 EP disclosed
EP-2385032-A1 GPR40 Receptor function regulator Takeda Pharmaceutical Company Limited (JP) 2011-11-09 EP disclosed
US-7960369-B2 Receptor function regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-06-14 US disclosed
US-20090012093-A1 Receptor Function Regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-01-08 US disclosed
EP-1559422-A1 RECEPTOR FUNCTION CONTROLLING AGENT Takeda Pharmaceutical Company Limited (JP) 2005-08-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090012093-A1 Receptor Function Regulator GPR119, GIPR, INSR FFAR1 33/4885FFAR4 44/4885ADRB2 316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.